China National Medicines Corporation Ltd.
600511
Rank in Stocks
#4965
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Share Price
$3.89
Market Cap
$2.93B
Change (1 day)
-1.72%
Change (1 year)
-3.28%
Country
CN
Trade China National Medicines Corporation Ltd. (600511)
Category
Healthcare
Number of shares outstanding for China National Medicines Corporation Ltd. (600511)
Number of shares outstanding as of June 2026: 722.47M
According to China National Medicines Corporation Ltd. latest financial reports and stock price the company's current number of shares outstanding is 722.47M. At the end of December 2023 the company had 754.50M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for China National Medicines Corporation Ltd. (600511) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 722.47M | -4.25% |
| 2024 | 754.51M | 0.00% |
| 2023 | 754.50M | 0.00% |
| 2022 | 754.50M | 0.00% |
| 2021 | 754.50M | 0.00% |
| 2020 | 754.50M | -0.98% |
| 2019 | 761.95M | -0.62% |
| 2018 | 766.72M | 4.14% |
| 2017 | 736.25M | 6.20% |
| 2016 | 693.26M | 44.79% |
| 2015 | 478.80M | 0.00% |
| 2014 | 478.82M | 0.01% |
| 2013 | 478.78M | 0.00% |
| 2012 | 478.78M | -0.01% |
| 2011 | 478.84M | 0.01% |
| 2010 | 478.79M | 0.01% |
| 2009 | 478.76M | -0.01% |
| 2008 | 478.82M | 0.00% |
| 2007 | 478.83M | 0.00% |
| 2006 | 478.82M | 0.00% |
| 2005 | 478.82M | 0.00% |
| 2004 | 478.82M | 0.00% |
| 2003 | 478.82M | 0.00% |
| 2002 | 478.82M | 0.00% |
| 2001 | 478.82M | 0.00% |
| 2000 | 478.82M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 118.70M | -83.57% |
US
|
|
| - | - |
US
|
|
| 236.00M | -67.33% |
US
|
|
| - | - |
US
|
|
| 11.50B | 1,492.14% |
AU
|
